A Safety and Efficacy Study of OnabotulinumtoxinA in Premature Ejaculation
Public ClinicalTrials.gov record NCT01917006. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Exploratory Study of the Safety and Efficacy of BOTOX® for the Treatment of Premature Ejaculation
Study identification
- NCT ID
- NCT01917006
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Allergan
- Industry
- Enrollment
- 59 participants
Conditions and interventions
Conditions
Interventions
- OnabotulinumtoxinA Drug
- Normal Saline Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 50 Years
- Sex
- Male
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 6, 2013
- Primary completion
- Aug 14, 2017
- Completion
- Aug 14, 2017
- Last update posted
- Oct 17, 2018
2013 – 2017
United States locations
- U.S. sites
- 6
- U.S. states
- 5
- U.S. cities
- 6
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| San Diego Sexual Medicine | San Diego | California | 92120 | — |
| LA Biomedical Research Institute at Harbor-UCLA Medical Center | Torrance | California | 90502 | — |
| Connecticut Clinical Research Center | Middlebury | Connecticut | 06762 | — |
| Center for Marital and Sexual Health of South Florida | West Palm Beach | Florida | 33401 | — |
| Tulane University School of Medicine | New Orleans | Louisiana | 70112 | — |
| Manhattan Medical Research | New York | New York | 10016 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 4 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01917006, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 17, 2018 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01917006 live on ClinicalTrials.gov.